Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Botox
Pharma
Revance is being bought up by Crown Laboratories for $924M
After treading the commercial path alone for more than a year, Revance, maker of Botox rival Daxxify, has agreed to fly the Crown Laboratories flag.
Fraiser Kansteiner
Aug 12, 2024 2:45pm
AbbVie's Skyrizi continues booming growth trajectory
Apr 26, 2024 12:06pm
AbbVie starts open casting call for next faces of Botox ads
Apr 24, 2024 8:40am
Public Citizen: FDA must cut ‘misleading’ promotions of Botox
Dec 12, 2023 9:59am
Hoping to challenge AbbVie's Botox, Revance cuts Daxxify's price
Sep 20, 2023 8:40am
AbbVie's Botox aces phase 3 study in another cosmetic use
Sep 18, 2023 3:05pm
